RESUMO
AIM: To estimate the prevalence of hepatitis C virus (HCV) infection in patients with end-stage renal disease (ESRD) undergoing hemodialysis in Latin America and the Caribbean (LAC). MATERIALS AND METHODS: Observational studies published in Spanish, Portuguese, and English language by November 25, 2021, in PubMed, Embase, Web of Science, Scopus, SciELO, and LILACS were selected by two reviewers according to predefined eligibility criteria. Study quality was assessed using the US National Heart, Lung and Blood Institute tool for observational cohort and cross-sectional studies. A meta-analysis of proportions was performed using a random-effects model based on the DerSimonian and Laird method, using R. PROSPERO N°: CRD42018107403. RESULTS: A total of 20 studies were included in the narrative synthesis (15 from Brazil, two from Cuba, two from Argentina, and one from Peru). Only 17 studies were included in the meta-analysis (13 from Brazil, two from Argentina, one from Cuba, and one from Peru). The overall prevalence of HCV in ESRD patients undergoing hemodialysis in LAC was 11.3% (95% confidence interval [CI]: 8.9% - 13.9%; I2: 99 %). In Brazil and Argentina, the prevalence was 6% and 26.1%, respectively. Prevalence after excluding poor-quality studies was 10.7%. CONCLUSION: The prevalence of HCV in ESRD patients undergoing hemodialysis in LAC was 11.3%. The implementation of infection control measures in hemodialysis centers in LAC is required. It is also necessary to increase the number of studies on the subject in the ESRD population in most LAC countries.
Assuntos
Hepatite C , Falência Renal Crônica , Humanos , Hepacivirus/genética , Estudos Transversais , Hepatite C/complicações , Hepatite C/epidemiologia , América Latina/epidemiologia , Prevalência , Falência Renal Crônica/complicações , Falência Renal Crônica/epidemiologiaRESUMO
OBJECTIVE: To estimate and analyze the evolution of mortality rates of gastrointestinal (GI) cancer in Peru and its regions between 2005-2014. MATERIAL AND METHODS: We performed a nationwide secondary analysis of Peru's Health Ministry registry of deaths during the period 2005-2014, with a focus on regional differences. Deaths registered with codes C15 to C25 (malignant neoplasms of digestive organs) from the ICD-10 were included. Calculation of age-standarized mortality rates and years of life lost (YLL) due to GI cancer per 100,000 habitants were also performed. RESULTS: Data of 67,527 deaths from GI cancers was analyzed, 35,055 (51.91%) were women. In 2005, the number of GI cancer deaths was 6,484, for 2014, 7,532 cases were recorded. The GI cancer age-standarized mortality rates at the country level showed a decrease of 12.70% between 2005-2014. Stomach cancer presented the highest age-standarized mortality rate despite showing a downward trend in the last years, equal for gallbladder, liver and biliary tract, and esophagus cancer. Colorectal, small intestine and anus cancer show a progressive increase. In 2014, Callao (48.8), Huancavelica (48.5), La Libertad (39.6), Lambayeque (40.5) and Huanuco (38.9) had the highest rates. The three types of GI cancers with the highest rates of YLL in 2014 were stomach cancer (118.51), followed by liver and biliary tract cancer (58.68) and colorectal (44.86). CONCLUSION: GI cancer mortality in Peru is high and a priority issue in regions like Huancavelica, Huanuco, Callao, La Libertad and Lambayeque. Stomach cancer remains the most frequent GI cancer, but with a downward trend in the study period.
Assuntos
Neoplasias Gastrointestinais/mortalidade , Feminino , Humanos , Expectativa de Vida , Masculino , Peru/epidemiologia , Sistema de RegistrosRESUMO
In order to determine the trend and characteristics of the manuscripts received and rejected in the Peruvian Journal of Experimental Medicine and Public Health (RPMESP), the manuscripts that followed the editorial process from 2011 to 2017 were analyzed, according to the type of manuscript, characteristics of the corresponding author, and rejection decisions. An increase in manuscripts received was found, from 283 in 2011 to 495 in 2017. Corresponding authors from abroad, from the provinces of Peru, and females presented an increase in the total contribution of manuscripts, as well as originals. The global average rejection was 63.1%: 55.8% in 2011 and 74.7% in 2017. The non-acceptance of original manuscripts prior to peer review was mainly due to deficiencies in style and format (51.5%). There is an increase in the reception of manuscripts, with differences according to the characteristics of the corresponding author.
Con el objetivo de determinar la tendencia y características de los manuscritos recibidos y rechazados en la Revista Peruana de Medicina Experimental y Salud Pública (RPMESP) se analizaron los manuscritos que siguieron el proceso editorial del 2011 a 2017 según tipo de manuscrito, características del autor corresponsal y decisiones de rechazo. Se encontró un incremento de manuscritos recibidos de 283 en el 2011 a 495 en el 2017. Los autores corresponsales del extranjero, de provincias del Perú, y del género femenino presentaron un incremento en la contribución total de manuscritos, así como de originales. El promedio global de rechazo fue de 63,1%, siendo 55,8% en el 2011 y 74,7% en el 2017. La no aceptación de los manuscritos originales antes de ser enviados a revisión por pares fue principalmente por deficiencias en el estilo y formato (51,5%). Se evidencia un incremento en la recepción y rechazo de manuscritos, con diferencias según características del autor corresponsal.
Assuntos
Políticas Editoriais , Publicações Periódicas como Assunto/estatística & dados numéricos , Saúde Pública , Editoração/estatística & dados numéricos , Autoria , Pesquisa Biomédica , Tomada de Decisões , Feminino , Humanos , Masculino , PeruRESUMO
RESUMEN Objetivo: Caracterizar las publicaciones sobre Sistemas de Salud producidas en el Perú entre 2000-2020. El estudio: Estudio bibliométrico de publicaciones científicas sobre sistemas de salud en el Perú en revistas indizadas en bases de datos de PubMed y SciELO. Se incluyó revisiones narrativas, artículos originales con diseños transversales, retrospectivos o prospectivos. Se describieron las redes de colaboración de autores y las instituciones. Hallazgos: Se identificaron 136 unidades bibliográficas. Las instituciones con mayor producción fueron la Universidad Peruana Cayetano Heredia (24,52%), Ministerio de Salud (14,19%) y la Universidad Peruana de Ciencias Aplicadas (7,74%). El componente más estudiado fue la provisión de servicios (50%), con diseños descriptivos. 65,44% fue publicado entre 2015-2020, 35,29% en la Revista Peruana de Medicina Experimental y Salud Pública, 51,47% en inglés. El abordaje predominante fue el cualitativo (52,94%). Conclusiones: Las publicaciones sobre sistemas de salud se enfocaron en la prestación de servicios y predominaron los estudios cualitativos.
ABSTRACT Objective: To characterize the publications on Health Systems produced in Peru between 2000-2020. Study: A bibliometric study of the scientific publications on health systems in Peru was carried out in journals indexed in the PubMed and SciELO databases. Narrative reviews, original articles with cross-sectional, and retrospective or prospective designs, were included. Collaboration networks of authors and institutions were described. Findings: 136 bibliographic units were identified. The institutions with the highest production were Universidad Peruana Cayetano Heredia (24.52%), the Ministry of Health (14.19%) and the Universidad Peruana de Ciencias Aplicadas (7.74%). The most studied component was the provision of services (50%), with descriptive designs. 65.44% were published between 2015-2020 and 35.29% in the Revista Peruana de Medicina Experimental y Salud Pública. 51.47% of the articles were written in English. The predominant approach was qualitative (52.94%). Conclusions: The publications on health systems in the period studied focused on the provision of services; they were predominantly qualitative articles.
RESUMO
The aim of this study was to estimate and analyze the evolution of mortality rates due to suicide in Peru between 2004 and 2013. National death records from the Peruvian Ministry of Health were analyzed, calculating the regional mortality rates due to suicide standardized by age. Similarly, rates grouped in 5-year periods were geospatially projected. There were 3,162 cases of suicide (67.2% men); the age range with the highest incidence was 20 to 29 years (28.7%) and 49.2% were due to poisoning. Suicide rates increased from 0.46 (95% confidence interval [CI] = 0.38-0.55) to 1.13 (95% CI = 1.01-1.25) per 100,000 people from 2004 to 2013, respectively. The highest rates of suicide were identified in Pasco, Junín, Tacna, Moquegua, and Huánuco. The suicide issue in Peru requires a comprehensive approach that entails not just identifying the areas with the highest risk, but also studying its associated factors that may explain the regional variability observed.
Assuntos
Suicídio/estatística & dados numéricos , Adolescente , Adulto , Idoso , Feminino , Humanos , Incidência , Masculino , Pessoa de Meia-Idade , Peru/epidemiologia , Adulto JovemRESUMO
La revisión por pares es un proceso importante al permitir tomar decisiones previas a la publicación de un artículo. Sin embargo, existe escasa información en revistas científicas de Latinoamérica sobre los profesionales que participan en estos procesos. Este trabajo se propuso determinar la distribución geográfica y de género en la revisión por pares realizada en la Revista Peruana de Medicina Experimental y Salud Pública. Se analizaron las listas de agradecimiento de quienes participaron en la revisión por pares de esta revista desde el año 2010 hasta el 2017. El país de procedencia se identificó a partir de la afiliación institucional, mencionada inicialmente por los revisores, y para la identificación del género se utilizaron los nombres. En caso de existir duda con el género se realizó una búsqueda de imágenes y de perfiles académicos públicos disponibles en Internet. Se encontraron 1 628 menciones de agradecimientos a profesionales que participaron en la revisión por pares; el 60,4 por ciento (n = 983) fueron procedentes del extranjero, principalmente de España, México, Chile, Colombia y Argentina. El 71,1 por ciento (n = 1158) fueron revisores hombres y el 28,9 por ciento (n = 470) revisoras. según la procedencia de las revisoras, el 35,0 por ciento (n = 344) fueron del extranjero y el 19,6 por ciento (n = 126) de Perú; y en los revisores hombres el 65,0 por ciento fueron del extranjero y el 80,6 por ciento de Perú. La revisión por pares en una revista científica biomédica en Perú fue realizada principalmente por profesionales de otros países de habla hispana. Existe una brecha de género que es mayor para la participación de revisoras de Perú(AU)
Peer review is an important process that makes it possible to take decisions before the publication of an article. However, little information is available in Latin American scientific journals about the professionals involved in this process. The purpose of the study was to determine the geographic and gender distribution of peer review in the Peruvian Journal of Experimental Medicine and Public Health. Data about peer reviewers were obtained from the acknowledgements sections of journal issues published from 2010 to 2017. The country of origin was identified from the institutional affiliation reported by peer reviewers, and gender was derived from their proper names. In the event of doubt about a reviewer's gender, a search was conducted for images and public academic profiles available on the Internet. A total 1 628 acknowledgement mentions were found, 60.4percent (n = 983) of which referred to overseas reviewers, mainly from Spain, Mexico, Chile, Colombia and Argentina. 71.1percent (n = 1 158) of the reviewers were male and 28.9percent (n = 470) were female. 35.0percent (n = 344) of the female reviewers were foreign and 19.6percent (n = 126) were from Peru, whereas 65.0percent of the male reviewers were foreign and 80.6percent were from Peru. Peer review in a Peruvian biomedical scientific journal was mainly conducted by professionals from other Spanish-speaking countries. A gender gap was observed which is wider for participation of Peruvian female reviewers(AU)
Assuntos
Humanos , Revisão por Pares/métodos , Saúde Pública , Publicações Científicas e Técnicas , Manuscritos Médicos como Assunto , América LatinaRESUMO
RESUMEN Con el objetivo de determinar la tendencia y características de los manuscritos recibidos y rechazados en la Revista Peruana de Medicina Experimental y Salud Pública (RPMESP) se analizaron los manuscritos que siguieron el proceso editorial del 2011 a 2017 según tipo de manuscrito, características del autor corresponsal y decisiones de rechazo. Se encontró un incremento de manuscritos recibidos de 283 en el 2011 a 495 en el 2017. Los autores corresponsales del extranjero, de provincias del Perú, y del género femenino presentaron un incremento en la contribución total de manuscritos, así como de originales. El promedio global de rechazo fue de 63,1%, siendo 55,8% en el 2011 y 74,7% en el 2017. La no aceptación de los manuscritos originales antes de ser enviados a revisión por pares fue principalmente por deficiencias en el estilo y formato (51,5%). Se evidencia un incremento en la recepción y rechazo de manuscritos, con diferencias según características del autor corresponsal.
ABSTRACT In order to determine the trend and characteristics of the manuscripts received and rejected in the Peruvian Journal of Experimental Medicine and Public Health (RPMESP), the manuscripts that followed the editorial process from 2011 to 2017 were analyzed, according to the type of manuscript, characteristics of the corresponding author, and rejection decisions. An increase in manuscripts received was found, from 283 in 2011 to 495 in 2017. Corresponding authors from abroad, from the provinces of Peru, and females presented an increase in the total contribution of manuscripts, as well as originals. The global average rejection was 63.1%: 55.8% in 2011 and 74.7% in 2017. The non-acceptance of original manuscripts prior to peer review was mainly due to deficiencies in style and format (51.5%). There is an increase in the reception of manuscripts, with differences according to the characteristics of the corresponding author.
Assuntos
Feminino , Humanos , Masculino , Publicações Periódicas como Assunto/estatística & dados numéricos , Editoração/estatística & dados numéricos , Saúde Pública , Políticas Editoriais , Peru , Autoria , Tomada de Decisões , Pesquisa BiomédicaRESUMO
Objective: To estimate and analyze the evolution of mortality rates of gastrointestinal (GI) cancer in Peru and its regions between 2005-2014. Material and methods: We performed a nationwide secondary analysis of Peru's Health Ministry registry of deaths during the period 2005-2014, with a focus on regional differences. Deaths registered with codes C15 to C25 (malignant neoplasms of digestive organs) from the ICD-10 were included. Calculation of age-standarized mortality rates and years of life lost (YLL) due to GI cancer per 100,000 habitants were also performed. Results: Data of 67,527 deaths from GI cancers was analyzed, 35,055 (51.91%) were women. In 2005, the number of GI cancer deaths was 6,484, for 2014, 7,532 cases were recorded. The GI cancer age-standarized mortality rates at the country level showed a decrease of 12.70% between 2005-2014. Stomach cancer presented the highest age-standarized mortality rate despite showing a downward trend in the last years, equal for gallbladder, liver and biliary tract, and esophagus cancer. Colorectal, small intestine and anus cancer show a progressive increase. In 2014, Callao (48.8), Huancavelica (48.5), La Libertad (39.6), Lambayeque (40.5) and Huanuco (38.9) had the highest rates. The three types of GI cancers with the highest rates of YLL in 2014 were stomach cancer (118.51), followed by liver and biliary tract cancer (58.68) and colorectal (44.86). Conclusion: GI cancer mortality in Peru is high and a priority issue in regions like Huancavelica, Huanuco, Callao, La Libertad and Lambayeque. Stomach cancer remains the most frequent GI cancer, but with a downward trend in the study period.
Objetivo: Estimar y analizar la evolución de las tasas de mortalidad de cáncer gastrointestinal (GI) en el Perú y sus regiones entre 2005-2014. Material y métodos: Se realizó un análisis secundario del registro de defunciones del Ministerio de Salud de Perú para el período 2005-2014 con los códigos C15 a C25 (neoplasias malignas de los órganos digestivos) de la versión 10 de la Clasificación Internacional de Enfermedades, además se calculó tasas de mortalidad ajustadas y años de vida perdidos (AVP) debido a cánceres GI por 100 000 habitantes. Resultados: Se analizaron datos de 67 527 muertes por cáncer GI, 35 055 (51,91%) eran mujeres. En 2005, el número de muertes fueron 6484; en 2014, hubo 7532 casos. Las tasas de mortalidad ajustadas a nivel nacional mostraron una disminución del 12,70% entre 2005-2014. El cáncer de estómago presentó la mayor tasa de mortalidad ajustada a pesar de mostrar una tendencia a la baja en los últimos años, igual para el cáncer de la vesícula biliar, del hígado y vías biliares y esófago. El cáncer colorrectal, de intestino delgado y de ano, mostraron tendencia al aumento. En 2014, Callao (48,8), Huancavelica (48,5), La Libertad (39,6), Lambayeque (40,5) y Huánuco (38,9) tuvieron las tasas más altas. Los tres tipos de cáncer GI con las tasas más altas de AVP en 2014 fueron el cáncer de estómago (118,51), cáncer de hígado y vías biliares (58,68) y colorrectal (44,86). Conclusión: La mortalidad por cáncer GI en Perú es alta, siendo un tema prioritario en regiones como Huancavelica, Huánuco, Callao, La Libertad y Lambayeque. El cáncer de estómago sigue siendo el cáncer GI más frecuente, pero con una tendencia descendente.
Assuntos
Feminino , Humanos , Masculino , Neoplasias Gastrointestinais/mortalidade , Peru/epidemiologia , Sistema de Registros , Expectativa de VidaRESUMO
El objetivo del estudio fue estimar y analizar la evolución de las tasas de mortalidad por suicidios en el Perú entre los años 2004 y 2013. Se analizaron los registros nacionales de defunciones del Ministerio de Salud del Perú, calculando las tasas regionales de mortalidad por suicidios estandarizadas por edad. Asimismo, se proyectaron geoespacialmente las tasas agrupadas por quinquenios. Se identificaron 3162 casos de suicidios (67,2% hombres), el grupo etario con mayor incidencia fue el de 20 a 29 años (28,7%) y el 49,2% ocurrieron por envenenamiento. La tasa de suicidios pasó de 0,46 (IC 95%: 0,38-0,55) a 1,13 (IC 95%: 1,01-1,25) por 100 000 habitantes en el 2004 y 2013, respectivamente. Las mayores tasas se identificaron en Pasco, Junín, Tacna, Moquegua y Huánuco. El problema de los suicidios en Perú requiere de un abordaje integral que implica no solo identificar zonas con mayor riesgo, sino también estudiar sus factores asociados que podrían explicar la variabilidad regional observada.
The aim of this study was to estimate and analyze the evolution of mortality rates due to suicide in Peru between 2004 and 2013. National death records from the Peruvian Ministry of Health were analyzed, calculating the regional mortality rates due to suicide standardized by age. Similarly, rates grouped in 5-year periods were geospatially projected. There were 3,162 cases of suicide (67.2% men); the age range with the highest incidence was 20 to 29 years (28.7%) and 49.2% were due to poisoning. Suicide rates increased from 0.46 (95% confidence interval [CI] = 0.38-0.55) to 1.13 (95% CI = 1.01-1.25) per 100,000 people from 2004 to 2013, respectively. The highest rates of suicide were identified in Pasco, Junín, Tacna, Moquegua, and Huánuco. The suicide issue in Peru requires a comprehensive approach that entails not just identifying the areas with the highest risk, but also studying its associated factors that may explain the regional variability observed.